Cancer affects approximately 1 in 4 dogs, with nearly half of dogs over age 10 developing cancer. Evidence-based oncology combined with quality of life assessment guides welfare-centered treatment decisions.
Dog cancer welfare requires navigating the intersection of medical capability and quality of life. Modern veterinary oncology can offer aggressive treatment protocols — chemotherapy, radiation, surgery — that extend life but impose their own welfare costs through side effects, hospital visits, and treatment stress. The welfare-centered approach is not necessarily to refuse aggressive treatment, but to continuously assess whether the animal's quality of life during and after treatment justifies the welfare costs. Dogs cannot consent to treatment and cannot articulate their experience of side effects — owners and veterinarians must develop quality of life assessment skills that go beyond tumor response rates. Tools like the FETCH-A Quality of Life scoring system provide structured frameworks for tracking dog wellbeing during cancer treatment. The goal is neither maximum life extension nor premature euthanasia, but the longest period of good quality of life achievable.